Treatment of Depression in Women

Christina Bourne, Laura Kenkel

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Women are more likely than men to experience depression throughout the life span. Sex differences in neurochemistry and brain structure, as well as societal factors may contribute to women’s increased likelihood of depression. Pharmacological research targeting depression has historically excluded women, leading to a knowledge gap regarding effective antidepressant treatment in women. Antidepressant pharmacokinetics and pharmacodynamics are clearly different in men and women, necessitating a thoughtful approach to their prescription and management. Hormone changes associated with the menstrual cycle, pregnancy, and menopause also contribute to differences in depression and effective antidepressant use in women. Finally, it is important to consider potential interactions between antidepressant drugs and medications specifically used by women (oral contraceptives, tamoxifen, and estrogen).

Original languageEnglish (US)
Title of host publicationHandbook of Experimental Pharmacology
PublisherSpringer New York LLC
Pages371-387
Number of pages17
DOIs
StatePublished - Jan 1 2019

Publication series

NameHandbook of Experimental Pharmacology
Volume250
ISSN (Print)0171-2004
ISSN (Electronic)1865-0325

Fingerprint

Antidepressive Agents
Pharmacodynamics
Pharmacokinetics
Tamoxifen
Therapeutics
Oral Contraceptives
Brain
Estrogens
Neurochemistry
Hormones
Menstrual Cycle
Menopause
Sex Characteristics
Prescriptions
Pharmacology
Pregnancy
Research

Keywords

  • Antidepressant
  • Depression
  • Estrogen
  • Hormones
  • Menopause
  • Menstrual cycle
  • Oral contraceptives
  • Postpartum
  • Pregnancy
  • Premenstrual
  • Sex differences
  • Tamoxifen
  • Women

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Bourne, C., & Kenkel, L. (2019). Treatment of Depression in Women. In Handbook of Experimental Pharmacology (pp. 371-387). (Handbook of Experimental Pharmacology; Vol. 250). Springer New York LLC. https://doi.org/10.1007/164_2018_163

Treatment of Depression in Women. / Bourne, Christina; Kenkel, Laura.

Handbook of Experimental Pharmacology. Springer New York LLC, 2019. p. 371-387 (Handbook of Experimental Pharmacology; Vol. 250).

Research output: Chapter in Book/Report/Conference proceedingChapter

Bourne, C & Kenkel, L 2019, Treatment of Depression in Women. in Handbook of Experimental Pharmacology. Handbook of Experimental Pharmacology, vol. 250, Springer New York LLC, pp. 371-387. https://doi.org/10.1007/164_2018_163
Bourne C, Kenkel L. Treatment of Depression in Women. In Handbook of Experimental Pharmacology. Springer New York LLC. 2019. p. 371-387. (Handbook of Experimental Pharmacology). https://doi.org/10.1007/164_2018_163
Bourne, Christina ; Kenkel, Laura. / Treatment of Depression in Women. Handbook of Experimental Pharmacology. Springer New York LLC, 2019. pp. 371-387 (Handbook of Experimental Pharmacology).
@inbook{4f6a3253d57f408599dfa5289c44eb17,
title = "Treatment of Depression in Women",
abstract = "Women are more likely than men to experience depression throughout the life span. Sex differences in neurochemistry and brain structure, as well as societal factors may contribute to women’s increased likelihood of depression. Pharmacological research targeting depression has historically excluded women, leading to a knowledge gap regarding effective antidepressant treatment in women. Antidepressant pharmacokinetics and pharmacodynamics are clearly different in men and women, necessitating a thoughtful approach to their prescription and management. Hormone changes associated with the menstrual cycle, pregnancy, and menopause also contribute to differences in depression and effective antidepressant use in women. Finally, it is important to consider potential interactions between antidepressant drugs and medications specifically used by women (oral contraceptives, tamoxifen, and estrogen).",
keywords = "Antidepressant, Depression, Estrogen, Hormones, Menopause, Menstrual cycle, Oral contraceptives, Postpartum, Pregnancy, Premenstrual, Sex differences, Tamoxifen, Women",
author = "Christina Bourne and Laura Kenkel",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/164_2018_163",
language = "English (US)",
series = "Handbook of Experimental Pharmacology",
publisher = "Springer New York LLC",
pages = "371--387",
booktitle = "Handbook of Experimental Pharmacology",

}

TY - CHAP

T1 - Treatment of Depression in Women

AU - Bourne, Christina

AU - Kenkel, Laura

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Women are more likely than men to experience depression throughout the life span. Sex differences in neurochemistry and brain structure, as well as societal factors may contribute to women’s increased likelihood of depression. Pharmacological research targeting depression has historically excluded women, leading to a knowledge gap regarding effective antidepressant treatment in women. Antidepressant pharmacokinetics and pharmacodynamics are clearly different in men and women, necessitating a thoughtful approach to their prescription and management. Hormone changes associated with the menstrual cycle, pregnancy, and menopause also contribute to differences in depression and effective antidepressant use in women. Finally, it is important to consider potential interactions between antidepressant drugs and medications specifically used by women (oral contraceptives, tamoxifen, and estrogen).

AB - Women are more likely than men to experience depression throughout the life span. Sex differences in neurochemistry and brain structure, as well as societal factors may contribute to women’s increased likelihood of depression. Pharmacological research targeting depression has historically excluded women, leading to a knowledge gap regarding effective antidepressant treatment in women. Antidepressant pharmacokinetics and pharmacodynamics are clearly different in men and women, necessitating a thoughtful approach to their prescription and management. Hormone changes associated with the menstrual cycle, pregnancy, and menopause also contribute to differences in depression and effective antidepressant use in women. Finally, it is important to consider potential interactions between antidepressant drugs and medications specifically used by women (oral contraceptives, tamoxifen, and estrogen).

KW - Antidepressant

KW - Depression

KW - Estrogen

KW - Hormones

KW - Menopause

KW - Menstrual cycle

KW - Oral contraceptives

KW - Postpartum

KW - Pregnancy

KW - Premenstrual

KW - Sex differences

KW - Tamoxifen

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=85066816596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066816596&partnerID=8YFLogxK

U2 - 10.1007/164_2018_163

DO - 10.1007/164_2018_163

M3 - Chapter

T3 - Handbook of Experimental Pharmacology

SP - 371

EP - 387

BT - Handbook of Experimental Pharmacology

PB - Springer New York LLC

ER -